Many pharma and biopharma companies are moving in the direction of patient-centered drug development. But a recent survey that asked respondents about the most crucial elements of drug development painted a different picture: Issues such as patient adherence, patient dosing convenience, and impact on a patient’s likely drug regimen all received comparatively low rankings. That suggests room for growth in the patient-centered sphere.

In this playbook, we look at how a patient-centric outlook helps scientists tackle the key challenges of early drug development.

Download Now